McCarthy Christopher bought IDXG
August 20, 2026 · Form 4 insider transaction
McCarthy Christopher bought 277,009 shares of Interpace Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
277,009
Price
$0.00
Total value
N/A
InsiderMcCarthy Christopher
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 20, 2026
Filing dateAugust 20, 2026
Shares owned after323,800
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the conversion upon vesting of restricted stock units (RSUs) into shares of common stock of Interpace Biosciences, Inc. On August 20, 2026, the Reporting Person was granted 554,018 RSUs, of which 277,009 vested upon grant and 277,009 will vest on August 20, 2027, subject to the Reporting Person's continued service on such vesting date.